A Multicenter Analysis of the Outcome of Cancer Patients with Neutropenia and COVID-19 Optionally Treated with Granulocyte-Colony Stimulating Factor (G-CSF): A Comparative Analysis

A Multicenter Analysis of the Outcome of Cancer Patients with Neutropenia and COVID-19 Optionally Treated with Granulocyte-Colony Stimulating Factor (G-CSF): A Comparative Analysis

Background: Approximately 15% of patients infected by SARS-CoV-2 develop a distress syndrome secondary to a host hyperinflammatory response induced by a cytokine storm. Myelosuppression is associated with a higher risk of infections and mortality. There are data to support methods of management for...

Full description

Bibliographic Details
Main Authors: María Sereno, Ana María Jimenez-Gordo, Javier Baena-Espinar, Carlos Aguado, Xabier Mielgo, Ana Pertejo, Rosa Álvarez-Álvarez, Ana Sánchez, Jose Luis López, Raquel Molina, Ana López-Alfonso, Berta Hernández, Luis Enrique Chiara, Ana Manuela Martín, Ana López-Martín, Miriam Dorta, Ana Collazo-Lorduy, Enrique Casado, Ana Ramirez de Molina, Gonzalo Colmenarejo
Format: Article
Language:English
Published: MDPI AG 2021-08-01
Series:Cancers
Subjects:
COVID-19
neutropenia
G-CSF treatment
respiratory failure
Online Access:https://www.mdpi.com/2072-6694/13/16/4205

Internet

https://www.mdpi.com/2072-6694/13/16/4205

Similar Items